Literature DB >> 3050689

Episodic conjunctival inflammation after Stevens-Johnson syndrome.

C S Foster1, L P Fong, D Azar, K R Kenyon.   

Abstract

The authors studied the histopathologic, ultrastructural, and immunopathologic characteristics of conjunctiva from patients with Stevens-Johnson syndrome (SJS). A small subset of SJS patients with recurrent conjunctival inflammation unassociated with external factors such as lid margin keratinization, sicca syndrome, trichiasis, or entropion was identified. The ultrastructural and immunopathologic characteristics of the conjunctiva from these patients were distinctly different from those of the conjunctiva from SJS patients without recurrent conjunctivitis, and suggested an active, immunologically mediated inflammation. Vasculitis or perivasculitis, immunoreactant deposition in vessel walls, vascular basement membrane disruption, thickening, and reduplication, and a preponderance of helper T-lymphocytes, macrophages, and Langerhans' cells were the notable distinguishing features in those patients with recurrent conjunctival inflammation. This rare clinical syndrome may represent the ocular counterpart to recurrent dermal or oral mucosal erythema multiforme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050689     DOI: 10.1016/s0161-6420(88)33165-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  Conjunctival inflammation in the chronic phase of Stevens-Johnson syndrome.

Authors:  S Kawasaki; K Nishida; C Sotozono; A J Quantock; S Kinoshita
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

2.  Early pathological features of the cornea in toxic epidermal necrolysis.

Authors:  G P Williams; H S Mudhar; M Leyland
Journal:  Br J Ophthalmol       Date:  2007-03-14       Impact factor: 4.638

3.  Ectopic conjunctivalisation in Stevens-Johnson syndrome.

Authors:  S E Navon; P A Rubin
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

4.  The relationship between preoperative clinical scores and immunohistological evaluation of surgically resected tissues in chronic severe ocular surface diseases.

Authors:  Hidetoshi Tanioka; Satoshi Kawasaki; Chie Sotozono; Takahiro Nakamura; Tsutomu Inatomi; Shigeru Kinoshita
Journal:  Jpn J Ophthalmol       Date:  2010-02-12       Impact factor: 2.447

5.  The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.

Authors:  M Victoria De Rojas; John K G Dart; Valerie P J Saw
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

6.  Epithelial hyperproliferation and transglutaminase 1 gene expression in Stevens-Johnson syndrome conjunctiva.

Authors:  K Nishida; K Yamanishi; K Yamada; A Dota; S Kawasaki; A J Quantock; S Kinoshita
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

7.  Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid.

Authors:  Samer N Arafat; Ana M Suelves; Sandra Spurr-Michaud; James Chodosh; C Stephen Foster; Claes H Dohlman; Ilene K Gipson
Journal:  Ophthalmology       Date:  2013-08-17       Impact factor: 12.079

8.  Elevation of conjunctival epithelial CD45INTCD11b⁺CD16⁺CD14⁻ neutrophils in ocular Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Geraint P Williams; Paul J Tomlins; Alastair K Denniston; H Susan Southworth; Sreekanth Sreekantham; S John Curnow; Saaeha Rauz
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-10       Impact factor: 4.799

Review 9.  [Classification of ocular surface disease. Part 1].

Authors:  F E Kruse; C Cursiefen; B Seitz; H E Völcker; G O H Naumann; L Holbach
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.174

10.  A case of recurrent bloody tears.

Authors:  Safak Karslıoğlu; Ilke Bahçeci Simşek; Müslime Akbaba
Journal:  Clin Ophthalmol       Date:  2011-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.